Ketogenic diet treatment in recurrent diffuse intrinsic pontine glioma in children: A safety and feasibility study
ConclusionUse of KD is safe and feasible, but the effect on survival has to be proven in a larger cohort of children who start the KD earlier after diagnosis, preferably as adjuvant therapy to fractionated radiotherapy. (Source: Pediatric Blood and Cancer)
Source: Pediatric Blood and Cancer - November 28, 2018 Category: Cancer & Oncology Authors: Elles J.T.M. der Louw, Roel E. Reddingius, Joanne F. Olieman, Rinze F. Neuteboom, Coriene E. Catsman ‐Berrevoets Tags: RESEARCH ARTICLE Source Type: research

Erratum
Pediatric Blood&Cancer, EarlyView. (Source: Pediatric Blood and Cancer)
Source: Pediatric Blood and Cancer - November 27, 2018 Category: Cancer & Oncology Tags: ERRATUM Source Type: research

Patients with “ALPS‐like phenotype” diagnosed with immune dysregulation due to LRBA deficiency
Pediatric Blood&Cancer, EarlyView. (Source: Pediatric Blood and Cancer)
Source: Pediatric Blood and Cancer - November 26, 2018 Category: Cancer & Oncology Authors: Karen S. Fern ández, Reuben Antony, Ashish Kumar Tags: LETTER TO THE EDITOR Source Type: research

Outcomes of observation without empiric intravenous antibiotics in febrile, nonneutropenic pediatric oncology patients
AbstractThere are no consensus guidelines for management of pediatric oncology patients presenting with fever and nonneutropenia, with limited research into the outcomes of withholding empiric i.v. antibiotics. We conducted a prospective cohort study assessing the safety and efficacy of observing well ‐appearing patients presenting with fever and nonneutropenia (absolute neutrophil count ≥ 500 cells/mm3). Of 238 episodes, 82.7% patients were observed with no infectious complications and low overall incidence of bacteremia (3.4%). There were no significant differences in individual clinical variables. We propose that o...
Source: Pediatric Blood and Cancer - November 26, 2018 Category: Cancer & Oncology Authors: Natalie Wu, William Muller, Elaine Morgan Tags: BRIEF REPORT Source Type: research

The challenge of defining “ultra‐high‐risk” neuroblastoma
AbstractGiven the biological and clinical heterogeneity of neuroblastoma, risk stratification is vital to determining appropriate treatment. Historically, most patients with high ‐risk neuroblastoma (HR‐NBL) have been treated uniformly without further stratification. Attempts have been made to identify factors that can be used to risk stratify these patients and to characterize an “ultra‐high‐risk” (UHR) subpopulation with particularly poor outcome. However, amon g published data, there is a lack of consensus in the definition of the UHR population and heterogeneity in the endpoints and statistical meth...
Source: Pediatric Blood and Cancer - November 26, 2018 Category: Cancer & Oncology Authors: Daniel A. Morgenstern, Rochelle Bagatell, Susan L. Cohn, Michael D. Hogarty, John M. Maris, Lucas Moreno, Julie R. Park, Andrew D. Pearson, Gudrun Schleiermacher, Dominique Valteau ‐Couanet, Wendy B. London, Meredith S. Irwin Tags: REVIEW Source Type: research

Pediatric cancer care can be complicated by language barriers: A case involving parents with limited Japanese proficiency
Pediatric Blood&Cancer, EarlyView. (Source: Pediatric Blood and Cancer)
Source: Pediatric Blood and Cancer - November 26, 2018 Category: Cancer & Oncology Authors: Kumiko Chino, Yuya Sasaki, Naoyuki Miyagawa, Bryn Meredith, Kara ‐Marie Delaney, Hiroaki Goto, Frances Rosario Tags: LETTER TO THE EDITOR Source Type: research

Novel mutation of the TINF2 gene resulting in severe phenotypic Revesz syndrome
Pediatric Blood&Cancer, EarlyView. (Source: Pediatric Blood and Cancer)
Source: Pediatric Blood and Cancer - November 26, 2018 Category: Cancer & Oncology Authors: Anusak Sakwit, Duangnate Rojanaporn, Pimsiri Mekjaruskul, Wiboon Suriyajakryuththana, Werasak Sasanakul, Nongnuch Sirachainan Tags: LETTER TO THE EDITOR Source Type: research

Understanding care and outcomes in adolescents and young adults with cancer: A review of the AYA HOPE study
AbstractHistorically, adolescents and young adults (AYA) diagnosed with cancer have been an understudied population, and their unique care experiences, needs, and outcomes were not well understood. Thus, 10 years ago, the National Cancer Institute supported the fielding of the Adolescent and Young Adult Health Outcomes and Patient Experiences (AYA HOPE) study to address this gap. We recruited individuals diagnosed at ages 15 to 39 with germ cell, Hodgkin and non ‐Hodgkin lymphoma, acute lymphoblastic leukemia, and sarcoma from Surveillance, Epidemiology, and End Results cancer registries into the first multicenter popula...
Source: Pediatric Blood and Cancer - November 21, 2018 Category: Cancer & Oncology Authors: Ashley Wilder Smith, Theresa Keegan, Ann Hamilton, Charles Lynch, Xiao ‐Cheng Wu, Stephen M. Schwartz, Ikuko Kato, Rosemary Cress, Linda Harlan, AYA HOPE Study Collaborative Group Tags: AYA ONCOLOGY: REVIEW Source Type: research

ASPHO Review Course (see http://aspho.org/meetings/2019-review-course/overview)
Pediatric Blood&Cancer, Volume 66, Issue 1, January 2019. (Source: Pediatric Blood and Cancer)
Source: Pediatric Blood and Cancer - November 21, 2018 Category: Cancer & Oncology Tags: ASPHO REVIEW COURSE Source Type: research

Issue Information
Pediatric Blood&Cancer, Volume 66, Issue 1, January 2019. (Source: Pediatric Blood and Cancer)
Source: Pediatric Blood and Cancer - November 21, 2018 Category: Cancer & Oncology Tags: ISSUE INFORMATION Source Type: research

Erratum
Pediatric Blood&Cancer, EarlyView. (Source: Pediatric Blood and Cancer)
Source: Pediatric Blood and Cancer - November 17, 2018 Category: Cancer & Oncology Tags: ERRATUM Source Type: research

Hydroxyurea for Primary Stroke Prevention: The time draweth nigh
Pediatric Blood&Cancer, EarlyView. (Source: Pediatric Blood and Cancer)
Source: Pediatric Blood and Cancer - November 14, 2018 Category: Cancer & Oncology Authors: Marvin E Reid Tags: COMMENTARY Source Type: research

Using the Patient ‐Reported Outcomes Measurement Information System (PROMIS) to measure symptom burden reported by patients with brain tumors
ConclusionsSignificant associations were found between PROMIS and SDS as well as clinical and demographic characteristics. Brief ‐yet‐precise PROMIS CATs can be used to systematically assess symptom burden experienced by children with brain tumors. (Source: Pediatric Blood and Cancer)
Source: Pediatric Blood and Cancer - November 14, 2018 Category: Cancer & Oncology Authors: Jin ‐Shei Lai, Mary Jo Kupst, Jennifer L. Beaumont, Peter E. Manley, John Han‐Chih Chang, William F. Hartsell, Young Kwok, Allison Piazza Fisher, Stewart Goldman Tags: RESEARCH ARTICLE Source Type: research

Social adjustment of adolescent cancer patients transitioning off active treatment: A short ‐term prospective mixed methods study
ConclusionsMost adolescent cancer patients are socially well adjusted as they transition off treatment, although a subset have elevated concerns. Interviews provide insight into complex social experiences not captured on questionnaires. Patients may benefit from screening and support during this unique time. (Source: Pediatric Blood and Cancer)
Source: Pediatric Blood and Cancer - November 14, 2018 Category: Cancer & Oncology Authors: Sherilynn F. Chan, Jennifer A. Hoag, Jeffrey S. Karst, Kristin M. Bingen Tags: RESEARCH ARTICLE Source Type: research

Only strongly enhanced residual FDG uptake in early response PET (Deauville 5 or qPET ≥ 2) is prognostic in pediatric Hodgkin lymphoma: Results of the GPOH‐HD2002 trial
AbstractPurposeIn 2014, we published the qPET method to quantify fluorodeoxyglucose positron emission tomography (FDG ‐PET) responses. Analysis of the distribution of the quantified signals suggested that a clearly abnormal FDG‐PET response corresponds to a visual Deauville score (vDS) of 5 and high qPET values ≥ 2. Evaluation in long‐term outcome data is still pending. Therefore, we analyzed progression‐ free survival (PFS) by early FDG‐PET response in a subset of the GPOH‐HD2002 trial for pediatric Hodgkin lymphoma (PHL).Patients/MethodsPairwise FDG ‐PET scans for initial staging and early response asses...
Source: Pediatric Blood and Cancer - November 14, 2018 Category: Cancer & Oncology Authors: L. Kurch, D. Hasenclever, R. Kluge, T. Georgi, L. Tchavdarova, M. Golombeck, O. Sabri, A. Eggert, W. Brenner, K.W. Sykora, F.M. Bengel, C. Rossig, D. K örholz, M. Schäfers, T. Feuchtinger, P. Bartenstein, R.A. Ammann, T. Krause, C. Urb Tags: RESEARCH ARTICLE Source Type: research

Issue Information
Pediatric Blood&Cancer, Volume 66, Issue S1, January 2019. (Source: Pediatric Blood and Cancer)
Source: Pediatric Blood and Cancer - November 13, 2018 Category: Cancer & Oncology Tags: ISSUE INFORMATION Source Type: research

Abstracts from the 34th Annual Meeting of the Histiocyte Society Lisbon, Portugal, October 22 –23, 2018
Pediatric Blood&Cancer, Volume 66, Issue S1, January 2019. (Source: Pediatric Blood and Cancer)
Source: Pediatric Blood and Cancer - November 13, 2018 Category: Cancer & Oncology Tags: ABSTRACTS Source Type: research

Intravenous fosaprepitant for the prevention of chemotherapy ‐induced vomiting in children: A double‐blind, placebo‐controlled, phase III randomized trial
AbstractBackgroundFosaprepitant is a neurokinin ‐1 receptor antagonist, approved for the prevention of chemotherapy‐induced nausea and vomiting. The data on the use of fosaprepitant in children are limited and therefore we conducted a phase III randomized controlled trial.ProcedureChildren aged 1 ‐12 years scheduled to receive moderately or highly emetogenic chemotherapy were randomly assigned to arm‐A (fosaprepitant) or arm‐B (placebo). Children recruited to arm‐A received intravenous ondansetron plus dexamethasone followed by fosaprepitant infusion. Children recruited to arm‐B r eceived the same drugs ...
Source: Pediatric Blood and Cancer - November 13, 2018 Category: Cancer & Oncology Authors: Venkatraman Radhakrishnan, Archit Joshi, Jaikumar Ramamoorthy, Swaminathan Rajaraman, Prasanth Ganesan, Trivadi S. Ganesan, Manikandan Dhanushkodi, Tenali G. Sagar Tags: RESEARCH ARTICLE Source Type: research

Treatment and outcome of patients with thoracic tumors of the Ewing sarcoma family: A report from the Cooperative Weichteilsarkom Studiengruppe CWS ‐81, ‐86, ‐91, ‐96, and ‐2002P trials
ConclusionsPositive predictive factors for outcome are age ≤10 years, size ≤5 cm, and localization at the chest wall. Diverse IRS groups require individual treatment. (Source: Pediatric Blood and Cancer)
Source: Pediatric Blood and Cancer - November 12, 2018 Category: Cancer & Oncology Authors: Guido Seitz, Cristian Urla, Monika Sparber ‐Sauer, Andreas Schuck, Christian Vokuhl, Bernd Blank, Thomas Klingebiel, Bernarda Kazanowska, Jörg Fuchs, Ewa Koscielniak Tags: RESEARCH ARTICLE Source Type: research

Management of oral mucositis in pediatric patients receiving cancer therapy: A systematic review and meta ‐analysis
ConclusionThis review provided a comprehensive examination of available options for children who have OM. The results support the possibility of a positive effect of palifermin on reducing OM in children receiving cancer therapy. (Source: Pediatric Blood and Cancer)
Source: Pediatric Blood and Cancer - November 12, 2018 Category: Cancer & Oncology Authors: Fatemeh Mazhari, Alireza Sarraf Shirazi, Mahboubeh Shabzendehdar Tags: REVIEW Source Type: research

Physician perspectives on compassionate use in pediatric oncology
ConclusionIdentified perceived and actual barriers to compassionate use application submission suggest pediatric oncologists may benefit from educational resources and support to ensure children with cancer equal access to investigational agents and care. (Source: Pediatric Blood and Cancer)
Source: Pediatric Blood and Cancer - November 8, 2018 Category: Cancer & Oncology Authors: Scott Moerdler, Lindy Zhang, Elena Gerasimov, Chong Zhu, Tamar Wolinsky, Michael Roth, Nancy Goodman, Daniel A. Weiser Tags: RESEARCH ARTICLE Source Type: research

CD38 is not expressed in pediatric ALK ‐positive anaplastic large cell lymphoma
Pediatric Blood&Cancer, EarlyView. (Source: Pediatric Blood and Cancer)
Source: Pediatric Blood and Cancer - November 8, 2018 Category: Cancer & Oncology Authors: Rex K.H. Au ‐Yeung, Birgit Burkhardt, Wilhelm Woessmann, Wolfram Klapper Tags: LETTER TO THE EDITOR Source Type: research

The effect of preoperative chemotherapy on histological subtyping and staging of Wilms tumors: The United Kingdom Children's Cancer Study Group (UKCCSG) Wilms tumor trial 3 (UKW3) experience
ConclusionPCT significantly altered histological features and typing of WTs. It resulted in fewer stage III tumors, and staging discrepancies were equally represented in both groups. (Source: Pediatric Blood and Cancer)
Source: Pediatric Blood and Cancer - November 8, 2018 Category: Cancer & Oncology Authors: Gordan M. Vujani ć, Ellen D’Hooghe, Sergey D. Popov, Neil J. Sebire, Anna Kelsey Tags: RESEARCH ARTICLE Source Type: research

Malignant peripheral nerve sheath tumor: Transformation in a patient with neurofibromatosis type 2
AbstractMalignant peripheral nerve sheath tumor (MPNST) is a rare soft ‐tissue sarcoma with an unfavorable prognosis and limited therapeutic options. MPNSTs can be sporadic, but are often associated with neurofibromatosis (NF) 1 and usually arise from preexisting neurofibromas. MPNSTs in patients with NF2 have been reported in only exceedingly rare cases, and the mec hanisms underlying transformation into an MPNST have not been fully elucidated. Here, we describe the clinicopathological and genomic features of a peripheral nerve sheath tumor (PNST), with a primary diagnosis of a neurofibroma, as it transforms into a high...
Source: Pediatric Blood and Cancer - November 8, 2018 Category: Cancer & Oncology Authors: Laura Agresta, Ralph Salloum, Trent R. Hummel, Nancy Ratner, Francesco T. Mangano, Christine Fuller, Richard L. McMasters, Luke Pater, Blaise V. Jones, Sara Szabo, Joseph G. Pressey Tags: BRIEF REPORT Source Type: research

Adolescent survivors ’ information needs for transitions to postsecondary education and employment
ConclusionsAYA survivors and parents lack knowledge necessary to successfully transition to their goals after high school. Greater education is needed. (Source: Pediatric Blood and Cancer)
Source: Pediatric Blood and Cancer - November 8, 2018 Category: Cancer & Oncology Authors: Marnie Hauff, Regina Abel, Juliana Hersh, Jill Isenberg, Debra Spoljaric, Robert J. Hayashi, Allison A. King Tags: RESEARCH ARTICLE Source Type: research

The utility of routine surveillance screening with magnetic resonance imaging to detect tumor recurrence/progression in children with high ‐grade central nervous system tumors: a systematic review
ConclusionThere is a paucity of evidence to guide clinical practice as to the effectiveness of MRI surveillance in pediatric patients with high ‐grade CNS tumors. These studies do not clearly demonstrate benefit or harm for the practice. With more research needed, there is a role for researchers to build into future trials data collection on surveillance imaging to give more information for the assessment of imaging frequency and duration in asymptomatic patients. This is an important question not only to clinicians and patients and their families but also from a health service resource perspective. (Source: Pediatric Blood and Cancer)
Source: Pediatric Blood and Cancer - November 8, 2018 Category: Cancer & Oncology Authors: Simon P. Stevens, Caroline Main, Simon Bailey, Barry Pizer, Martin English, Bob Phillips, Andrew Peet, Shivaram Avula, Sophie Wilne, Keith Wheatley, Pamela R. Kearns, Jayne S. Wilson Tags: REVIEW Source Type: research

Transarterial radioembolization with yttrium ‐90 of unresectable primary hepatic malignancy in children
ConclusionTARE ‐Y90 of unresectable primary liver malignancy is both technically feasible and demonstrates an anticancer effect, and retreatment is well tolerated. TARE‐Y90 could be considered as adjunctive therapy in pediatric patients with unresectable hepatic malignancies and could be used as a bridge to su rgical resection or liver transplant. More research is required to determine the efficacy of this treatment in children and to define the clinical scenarios where benefit is likely to be optimized. (Source: Pediatric Blood and Cancer)
Source: Pediatric Blood and Cancer - November 8, 2018 Category: Cancer & Oncology Authors: Allison Aguado, Ross Ristagno, Alexander J. Towbin, Anita Gupta, Sinisa Haberle, Zhihua Qi, Manish N. Patel, Kamlesh U. Kukreja, Gregory M. Tiao, James I. Geller Tags: RESEARCH ARTICLE Source Type: research

Pediatric pain screening identifies youth at risk of chronic pain in sickle cell disease
Pediatric Blood&Cancer, EarlyView. (Source: Pediatric Blood and Cancer)
Source: Pediatric Blood and Cancer - November 5, 2018 Category: Cancer & Oncology Authors: Soumitri Sil, Lindsey L. Cohen, Carlton Dampier Source Type: research

How I approach iron deficiency with and without anemia
Pediatric Blood&Cancer, EarlyView. (Source: Pediatric Blood and Cancer)
Source: Pediatric Blood and Cancer - November 5, 2018 Category: Cancer & Oncology Authors: Jacquelyn M. Powers, Sarah H. O'Brien Source Type: research

Bone marrow transplant and pediatric multiple myeloma
Pediatric Blood&Cancer, EarlyView. (Source: Pediatric Blood and Cancer)
Source: Pediatric Blood and Cancer - November 5, 2018 Category: Cancer & Oncology Authors: Kimberly A. Davidow, Andrew W. Walter, E. Anders Kolb Source Type: research

Phase I study of vinblastine and temsirolimus in pediatric patients with recurrent or refractory solid tumors: Canadian Cancer Trials Group Study IND.218
Pediatric Blood&Cancer, EarlyView. (Source: Pediatric Blood and Cancer)
Source: Pediatric Blood and Cancer - November 5, 2018 Category: Cancer & Oncology Authors: Rebecca J. Deyell, Bing Wu, S. Rod Rassekh, Dongsheng Tu, Yvan Samson, Adam Fleming, Eric Bouffet, Xiaoqun Sun, Jean Powers, Lesley Seymour, Sylvain Baruchel, Daniel A. Morgenstern Source Type: research

Sentinel lymph node biopsy in head and neck rhabdomyosarcoma
Pediatric Blood&Cancer, EarlyView. (Source: Pediatric Blood and Cancer)
Source: Pediatric Blood and Cancer - November 5, 2018 Category: Cancer & Oncology Authors: Brian Turpin, Joseph G. Pressey, Rajaram Nagarajan, Brian D. Weiss, Andrew T. Trout, Michael J. Gelfand, Luke Pater, Ralph E. Vatner, John C. Breneman, Roshni Dasgupta Source Type: research

Second rhabdoid tumor 8 years after treatment of atypical teratoid/rhabdoid tumor in a child with germline SMARCB1 mutation
Pediatric Blood&Cancer, EarlyView. (Source: Pediatric Blood and Cancer)
Source: Pediatric Blood and Cancer - November 5, 2018 Category: Cancer & Oncology Authors: Mihir D. Bhatt, Salma Al ‐Karmi, Harriet Druker, Abha Gupta, Mei Lu, David Malkin, Gino Somers, Annie Huang, Eric Bouffet Source Type: research

Higher incidence of surgery ‐related complications in Wilms tumor nephrectomy from clinical records analysis compared with central database registration
Pediatric Blood&Cancer, EarlyView. (Source: Pediatric Blood and Cancer)
Source: Pediatric Blood and Cancer - November 5, 2018 Category: Cancer & Oncology Authors: Daan Poll, Jim Wilde, Kees de Ven, Maria Asimakidou, Hugo Heij, Marc Wijnen Source Type: research

Outcome for pediatric acute promyelocytic leukemia patients at Children's Oncology Group sites on the Leukemia Intergroup Study CALGB 9710 (Alliance)
Pediatric Blood&Cancer, EarlyView. (Source: Pediatric Blood and Cancer)
Source: Pediatric Blood and Cancer - November 5, 2018 Category: Cancer & Oncology Authors: Matthew A. Kutny, Susan Geyer, Kristina M. Laumann, John Gregory, Cheryl L. Willman, Wendy Stock, Richard A. Larson, Bayard L. Powell, James H. Feusner Source Type: research

Hereditary elliptocytosis ‐associated alpha‐spectrin mutation p.L155dup as a modifier of sickle cell disease severity
Pediatric Blood&Cancer, EarlyView. (Source: Pediatric Blood and Cancer)
Source: Pediatric Blood and Cancer - November 5, 2018 Category: Cancer & Oncology Authors: Mary Risinger, Georgios E. Christakopoulos, Corinna L. Schultz, Patrick T. McGann, Wenying Zhang, Theodosia A. Kalfa Source Type: research

Student perspectives on managing sickle cell disease at school
Pediatric Blood&Cancer, EarlyView. (Source: Pediatric Blood and Cancer)
Source: Pediatric Blood and Cancer - November 2, 2018 Category: Cancer & Oncology Authors: Naeha Haridasa, Michael R. DeBaun, Maureen Sanger, Tilicia L. Mayo ‐Gamble Source Type: research

Pediatric residents ’ perceived barriers to opioid use in sickle cell disease pain management
Pediatric Blood&Cancer, EarlyView. (Source: Pediatric Blood and Cancer)
Source: Pediatric Blood and Cancer - November 2, 2018 Category: Cancer & Oncology Authors: Amber Fearon, Anne Marsh, Jennifer Kim, Marsha Treadwell Source Type: research

Myelodysplastic syndrome with multilineage dysplasia evolving to acute myeloid leukemia: Noonan syndrome with c.218C > T mutation in PTPN11 gene
Pediatric Blood&Cancer, EarlyView. (Source: Pediatric Blood and Cancer)
Source: Pediatric Blood and Cancer - October 31, 2018 Category: Cancer & Oncology Authors: Rathika Damodara Shenoy, Sunil Kumar Yeshvanth, Harsha Prasada L, Vijaya Shenoy, Vikram Shetty Source Type: research

Survival and characteristics of pediatric salivary gland cancer: A systematic review and meta ‐analysis
Pediatric Blood&Cancer, EarlyView. (Source: Pediatric Blood and Cancer)
Source: Pediatric Blood and Cancer - October 31, 2018 Category: Cancer & Oncology Authors: Martin Zamani, Christian Gr ønhøj, Jakob Schmidt Jensen, Christian Buchwald, Birgitte Wittenborg Charabi, Thomas Hjuler Source Type: research

A phase II study of eribulin in recurrent or refractory osteosarcoma: A report from the Children's Oncology Group
Pediatric Blood&Cancer, EarlyView. (Source: Pediatric Blood and Cancer)
Source: Pediatric Blood and Cancer - October 31, 2018 Category: Cancer & Oncology Authors: Michael S. Isakoff, Robert Goldsby, Doojduen Villaluna, Mark D. Krailo, Pooja Hingorani, Anderson Collier, Carol D. Morris, E. Anders Kolb, John J. Doski, Richard B. Womer, Richard Gorlick, Katherine A. Janeway Source Type: research

Integrated analysis of long ‐term growth and bone development in pediatric and adolescent patients receiving bevacizumab
Pediatric Blood&Cancer, EarlyView. (Source: Pediatric Blood and Cancer)
Source: Pediatric Blood and Cancer - October 31, 2018 Category: Cancer & Oncology Authors: Hermann L. M üller, Johannes H.M. Merks, Birgit Geoerger, Jacques Grill, Darren Hargrave, Julia Glade Bender, Sridharan Gururangan, Fariba Navid, Michael Johnston, Jeanette Bachir, Markus C. Elze, Sabine Fürst‐Recktenwald Source Type: research

Posttransplant recipient ‐derived CD4+T‐cell lymphoproliferative disease in X‐linked hyper‐IgM syndrome
Pediatric Blood&Cancer, EarlyView. (Source: Pediatric Blood and Cancer)
Source: Pediatric Blood and Cancer - October 31, 2018 Category: Cancer & Oncology Authors: Yasuaki Hagio, Akira Shiraishi, Masataka Ishimura, Motoshi Sonoda, Katsuhide Eguchi, Hidetaka Yamamoto, Yoshinao Oda, Shouichi Ohga Source Type: research

Obesity in pediatric patients with acute lymphoblastic leukemia increases the risk of adverse events during pre ‐maintenance chemotherapy
Pediatric Blood&Cancer, EarlyView. (Source: Pediatric Blood and Cancer)
Source: Pediatric Blood and Cancer - October 26, 2018 Category: Cancer & Oncology Authors: Chelsea K. Meenan, John A. Kelly, Li Wang, A. Kim Ritchey, Scott H Maurer Source Type: research

Outcome after surgery for solid pseudopapillary pancreatic tumors in children: Report from the TREP project —Italian Rare Tumors Study Group
Pediatric Blood&Cancer, EarlyView. (Source: Pediatric Blood and Cancer)
Source: Pediatric Blood and Cancer - October 26, 2018 Category: Cancer & Oncology Authors: Alessandro Crocoli, Chiara Grimaldi, Calogero Virgone, Maria Debora Pasquale, Giovanni Cecchetto, Simone Cesaro, Gianni Bisogno, Valerio Cecinati, Alessandra Narciso, Daniele Alberti, Andrea Ferrari, Patrizia Dall'Igna, Marco Spada, Alessandr Source Type: research

Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy: A safe treatment option for intraperitoneal rhabdomyosarcoma in children below 5 years of age
Pediatric Blood&Cancer, EarlyView. (Source: Pediatric Blood and Cancer)
Source: Pediatric Blood and Cancer - October 26, 2018 Category: Cancer & Oncology Authors: Jens Gesche, Stefan Beckert, Felix Neunhoeffer, Denis Kachanov, Alfred K önigsrainer, Guido Seitz, Jörg Fuchs Source Type: research

Just tell me: A bereaved parent's thoughts on expressing condolences and longitudinal remembering to a family after the death of their child
Pediatric Blood&Cancer, EarlyView. (Source: Pediatric Blood and Cancer)
Source: Pediatric Blood and Cancer - October 26, 2018 Category: Cancer & Oncology Authors: Tasha Ives Source Type: research

Future health of AYA survivors
Pediatric Blood&Cancer, EarlyView. (Source: Pediatric Blood and Cancer)
Source: Pediatric Blood and Cancer - October 26, 2018 Category: Cancer & Oncology Authors: Madelyn Burkart, Stacy Sanford, Shira Dinner, Lisa Sharp, Karen Kinahan Source Type: research

Virtual reality as complementary pain therapy in hospitalized patients with sickle cell disease
Pediatric Blood&Cancer, EarlyView. (Source: Pediatric Blood and Cancer)
Source: Pediatric Blood and Cancer - October 26, 2018 Category: Cancer & Oncology Authors: Anurag K. Agrawal, Simon Robertson, Liat Litwin, Erica Tringale, Marsha Treadwell, Carolyn Hoppe, Anne Marsh Source Type: research